- Home
- Publications
- Publication Search
- Publication Details
Title
Riociguat: Clinical research and evolving role in therapy
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-11-27
DOI
10.1111/bcp.14676
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction
- (2020) Paul W. Armstrong et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk Assessment in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension
- (2019) Marc Humbert et al. EUROPEAN RESPIRATORY JOURNAL
- Riociguat for idiopathic interstitial pneumonia-associated pulmonary hypertension (RISE-IIP): a randomised, placebo-controlled phase 2b study
- (2019) Steven D Nathan et al. Lancet Respiratory Medicine
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Catalytic receptors
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
- (2019) Stephen P H Alexander et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Low-Risk Profile in Pulmonary Arterial Hypertension. Time for a Paradigm Shift to Goal-oriented Clinical Trial Endpoints?
- (2018) Jason Weatherald et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival
- (2018) Raymond L. Benza et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat
- (2018) Raymond L. Benza et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Riociguat for the Treatment of Raynaud’s Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Pilot Study (DIGIT)
- (2018) Michael Huntgeburth et al. CLINICAL DRUG INVESTIGATION
- Haemodynamic definitions and updated clinical classification of pulmonary hypertension
- (2018) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- Risk stratification and medical therapy of pulmonary arterial hypertension
- (2018) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients
- (2018) Marion Delcroix et al. EUROPEAN RESPIRATORY JOURNAL
- A comprehensive risk stratification at early follow-up determines prognosis in pulmonary arterial hypertension
- (2017) David Kylhammar et al. EUROPEAN HEART JOURNAL
- RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors
- (2017) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model
- (2017) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension
- (2017) Athénaïs Boucly et al. EUROPEAN RESPIRATORY JOURNAL
- Rationale and study design of RESPITE: An open-label, phase 3b study of riociguat in patients with pulmonary arterial hypertension who demonstrate an insufficient response to treatment with phosphodiesterase-5 inhibitors
- (2017) Marius M. Hoeper et al. RESPIRATORY MEDICINE
- Anti-fibrotic effects of soluble guanylate cyclase stimulators and activators: A review of the preclinical evidence
- (2017) Peter Sandner et al. RESPIRATORY MEDICINE
- Riociguat for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: Results from a phase II long-term extension study
- (2017) Michael Halank et al. RESPIRATORY MEDICINE
- Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study
- (2017) Vallerie V. McLaughlin et al. BMC Pulmonary Medicine
- Long-Term Effect of Endothelin Receptor Antagonism With Bosentan on the Morbidity and Mortality of Patients With Severe Chronic Heart Failure
- (2017) Milton Packer et al. JACC-Heart Failure
- Riociguat for the treatment of pulmonary arterial hypertension associated with connective tissue disease: results from PATENT-1 and PATENT-2
- (2016) Marc Humbert et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Riociguat in Treatment-Naive vs Pretreated Patients With Pulmonary Arterial Hypertension: 2-Year Efficacy Results From the PATENT-2 Study
- (2016) J. Wesley McConnell et al. CHEST
- Dynamic Risk Stratification of Patient Long-Term Outcome After Pulmonary EndarterectomyCLINICAL PERSPECTIVE
- (2016) John E. Cannon et al. CIRCULATION
- Haemodynamic effects of riociguat in inoperable/recurrent chronic thromboembolic pulmonary hypertension
- (2016) Nick H Kim et al. HEART
- Evaluation of the pharmacoDYNAMIC effects of riociguat in subjects with pulmonary hypertension and heart failure with preserved ejection fraction
- (2016) Julia Mascherbauer et al. WIENER KLINISCHE WOCHENSCHRIFT
- Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial
- (2016) Hossein-Ardeschir Ghofrani et al. Lancet Respiratory Medicine
- Predictors of long-term outcomes in patients treated with riociguat for chronic thromboembolic pulmonary hypertension: data from the CHEST-2 open-label, randomised, long-term extension trial
- (2016) Gérald Simonneau et al. Lancet Respiratory Medicine
- Stimulators of soluble guanylate cyclase (sGC) inhibit experimental skin fibrosis of different aetiologies
- (2015) Clara Dees et al. ANNALS OF THE RHEUMATIC DISEASES
- Riociguat in Combination With Prostacyclin Analogs for the Treatment of Pulmonary Arterial Hypertension (PAH): A Subgroup Analysis of the PATENT Studies
- (2015) Ioana Preston et al. CHEST
- 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN HEART JOURNAL
- Riociguat for the treatment of pulmonary arterial hypertension: a long-term extension study (PATENT-2)
- (2015) Lewis J. Rubin et al. EUROPEAN RESPIRATORY JOURNAL
- PATENT PLUS: a blinded, randomised and extension study of riociguat plus sildenafil in pulmonary arterial hypertension
- (2015) Nazzareno Galiè et al. EUROPEAN RESPIRATORY JOURNAL
- Riociguat for pulmonary arterial hypertension associated with congenital heart disease
- (2015) Stephan Rosenkranz et al. HEART
- Use of responder threshold criteria to evaluate the response to treatment in the phase III CHEST-1 study
- (2015) Andrea M. D’Armini et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Use of clinically relevant responder threshold criteria to evaluate the response to treatment in the Phase III PATENT-1 study
- (2015) David Langleben et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Prognostic implications of serial risk score assessments in patients with pulmonary arterial hypertension: A Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) analysis
- (2015) Raymond L. Benza et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- The molecular targets of approved treatments for pulmonary arterial hypertension
- (2015) Marc Humbert et al. THORAX
- Acute Effects of Riociguat in Borderline or Manifest Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease
- (2015) Hossein A. Ghofrani et al. Pulmonary Circulation
- Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1)
- (2014) Diana Bonderman et al. CHEST
- Riociguat for the treatment of chronic thromboembolic pulmonary hypertension: a long-term extension study (CHEST-2)
- (2014) Gérald Simonneau et al. EUROPEAN RESPIRATORY JOURNAL
- The Chemistry and Biology of Soluble Guanylate Cyclase Stimulators and Activators
- (2013) Markus Follmann et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Riociguat for Patients With Pulmonary Hypertension Caused by Systolic Left Ventricular Dysfunction
- (2013) Diana Bonderman et al. CIRCULATION
- Development and validation of the living with pulmonary hypertension questionnaire in pulmonary arterial hypertension patients
- (2013) Nicola Bonner et al. Health and Quality of Life Outcomes
- Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
- (2013) Margaret M. Redfield et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Chronic Thromboembolic Pulmonary Hypertension
- (2013) Nick H. Kim et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Riociguat for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Riociguat for the Treatment of Pulmonary Arterial Hypertension
- (2013) Hossein-Ardeschir Ghofrani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of Chloride Transport and Mislocalization of CFTR Protein by Vardenafil in the Gastrointestinal Tract of Cystic Fibrosis Mice
- (2013) Barbara Dhooghe et al. PLoS One
- Riociguat for interstitial lung disease and pulmonary hypertension: a pilot trial
- (2012) Marius M. Hoeper et al. EUROPEAN RESPIRATORY JOURNAL
- Tadalafil for the Treatment of Pulmonary Arterial Hypertension
- (2012) Ronald J. Oudiz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
- (2012) Jennifer C. Irvine et al. PLoS One
- Long-term Treatment With Sildenafil Citrate in Pulmonary Arterial Hypertension
- (2011) Lewis J. Rubin et al. CHEST
- The REVEAL Registry Risk Score Calculator in Patients Newly Diagnosed With Pulmonary Arterial Hypertension
- (2011) Raymond L. Benza et al. CHEST
- Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- (2011) Joanna Pepke-Zaba et al. CIRCULATION
- Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary Disease
- (2011) Johannes-Peter Stasch et al. CIRCULATION
- ASPIRE registry: Assessing the Spectrum of Pulmonary hypertension Identified at a REferral centre
- (2011) J. Hurdman et al. EUROPEAN RESPIRATORY JOURNAL
- Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: Results from an international prospective registry
- (2011) Eckhard Mayer et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Mechanisms of disease: pulmonary arterial hypertension
- (2011) Ralph T. Schermuly et al. Nature Reviews Cardiology
- Soluble Guanylate Cyclase Stimulation Prevents Fibrotic Tissue Remodeling and Improves Survival in Salt-Sensitive Dahl Rats
- (2011) Sandra Geschka et al. PLoS One
- Predicting Survival in Pulmonary Arterial Hypertension
- (2010) Raymond L. Benza et al. CIRCULATION
- Riociguat for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension: a phase II study
- (2010) H. A. Ghofrani et al. EUROPEAN RESPIRATORY JOURNAL
- Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models
- (2010) Yuliya Sharkovska et al. JOURNAL OF HYPERTENSION
- Survival after pulmonary thromboendarterectomy: Effect of residual pulmonary hypertension
- (2010) Darren H. Freed et al. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
- Discovery of Riociguat (BAY 63-2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension
- (2009) Joachim Mittendorf et al. ChemMedChem
- First acute haemodynamic study of soluble guanylate cyclase stimulator riociguat in pulmonary hypertension
- (2009) F. Grimminger et al. EUROPEAN RESPIRATORY JOURNAL
- Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart
- (2009) Hiroyuki Masuyama et al. HYPERTENSION RESEARCH
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) Vallerie V. McLaughlin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Single-Dose Pharmacokinetics, Pharmacodynamics, Tolerability, and Safety of the Soluble Guanylate Cyclase Stimulator BAY 63-2521: An Ascending-Dose Study in Healthy Male Volunteers
- (2008) Reiner Frey et al. JOURNAL OF CLINICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started